Skip to main content

Table 4 Levels of inflammatory biomarkers

From: A randomised controlled trial on roles of prostaglandin E1 nebulization among patients undergoing one lung ventilation

Biomarkers

Group

T1

T5

T7

T8

IL-6, pg/mL

A

5.15 ± 2.76

23.78 ± 4.51

38.45 ± 10.59

64.97 ± 7.22

B

4.96 ± 2.49

23.86 ± 4.97

39.53 ± 6.84

58.54 ± 7.42a

C

4.92 ± 2.62

23.13 ± 4.04

37.52 ± 5.49

54.63 ± 7.11ab

MDA, nmol/mL

A

7.95 ± 3.08

7.77 ± 2.40

8.00 ± 2.73

7.02 ± 1.93

B

6.54 ± 2.54

6.73 ± 2.88a

5.7 ± 2.05a

5.92 ± 2.53

C

6.34 ± 2.48

5.68 ± 1.88ab

5.68 ± 2.22a

6.65 ± 2.43

SOD, U/mL

A

60.13 ± 9.32

57.12 ± 13.18

56.06 ± 10.26

58.21 ± 12.41

B

64.29 ± 7.28

63.09 ± 7.4

60.44 ± 7.05

61.83 ± 4.83

C

64.32 ± 7.57

61.17 ± 7.2

60.99 ± 7.16

63.07 ± 6.07

TNF-α, pg/mL

A

1.00 ± 0.40

1.89 ± 0.91

2.68 ± 0.70

3.03 ± 0.65

B

0.82 ± 0.23

1.88 ± 0.4

2.66 ± 0.45

3.3 ± 0.86

C

0.94 ± 0.49

1.91 ± 0.58

2.5 ± 0.35

2.81 ± 0.55ab

  1. aP < 0.05 compared with Group A; bP < 0.05 compared with Group B
  2. IL-6, interleukin-6; MDA, malondialdehyde; SOD, superoxide dismutase; TNF-α, tumor necrosis factor-α
  3. T1, pre-nebulization; T5, OLV 60 min; T7, TLV 30 min; T8, 24 h after surgery
  4. A, 60% FiO2 + 0.1 µg/kg PGE1; B, 40% FiO2 + 0.1 µg/kg PGE1; C, 40% FiO2 + 0.2 µg/kg PGE1